Biote Reaffirms 2024 Financial Guidance, With Acceleration In H2 Growth; Sees Revenue Of $200M-$204M, Est $203.167M; Adjusted EBITDA Of $60M-$63M
Biote Reaffirms 2024 Financial Guidance, With Acceleration In H2 Growth; Sees Revenue Of $200M-$204M, Est $203.167M; Adjusted EBITDA Of $60M-$63M
Biote重申了2024年的财务指导，下半年的增长加速；预计收入为2亿至2.04亿美元，约合2.03167亿美元；调整后的息税折旧摊销前利润为6000万至6300万美元
Previously, Biote projected fiscal 2024 revenue of greater than $200 million and Adjusted EBITDA of greater than $60 million. First half 2024 consolidated year-on-year revenue growth is expected to be in the low-single digits, with significant improvement expected in the second half of 2024. Total revenue growth in the first half of 2024 is expected to be impacted by the transition in the nutraceutical distribution channel and timing of seasonal promotions.
此前，Biote预计2024财年收入将超过2亿美元，调整后的息税折旧摊销前利润将超过6000万美元。2024年上半年的合并收入同比增长预计将处于较低的个位数，预计2024年下半年将出现显著改善。预计2024年上半年的总收入增长将受到营养品分销渠道过渡和季节性促销时机的影响。